Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#121 / 200 Total
ORLA - Orla Mining Ltd - Stock Price Chart
TickerORLA [AMEX]
CompanyOrla Mining Ltd
CountryCanada
IndustryGold
Market Cap1.32BEPS (ttm)-0.08
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y7.87%
P/S5.30EPS next 5Y-
P/B3.14EPS Q/Q31.53%
Dividend-Sales Q/Q31.58%
Insider Own52.74%Inst Own49.08%
Insider Trans0.00%Inst Trans-
Short Float3.95%EarningsMar 20/b
Analyst Recom-Target Price-
Avg Volume483.13K52W Range2.60 - 4.82
Orla Mining Ltd. is a capital pool company, which engages in the business of acquisition, exploration, development, and operation of mineral properties. Its material gold projects include Camino Rojo, South Railroad, and Cerro Quema. The company was founded on May 31, 2007 and is headquartered in Vancouver, Canada.
COIN - Coinbase Global Inc - Stock Price Chart
TickerCOIN [NASD]
CompanyCoinbase Global Inc
CountryUSA
IndustryFinancial Data & Stock Exchanges
Market Cap54.00BEPS (ttm)5.01
P/E43.92EPS this Y1711.50%
Forward P/E47.24EPS next Y-30.54%
PEG-EPS past 5Y-
P/S11.58EPS next 5Y-
P/B6.69EPS Q/Q1390.11%
Dividend-Sales Q/Q201.18%
Insider Own29.41%Inst Own42.23%
Insider Trans-4.87%Inst Trans-0.30%
Short Float6.16%EarningsMay 09/a
Analyst Recom2.61Target Price249.04
Avg Volume12.40M52W Range46.43 - 283.48
Coinbase Global, Inc. engages in technology and financial infrastructure products and services. It offers crypto-powered technologies including self-custody wallets, decentralized apps and services, and open community engagement platforms. The company was founded by Brian Armstrong in May 2012 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HAAS ALESIA JChief Financial OfficerMay 15 '24Sale212.155,0001,060,747187,622May 15 04:08 PM
Ehrsam Frederick Ernest IIIDirectorMay 14 '24Sale202.30114,21623,106,3670May 15 04:22 PM
Choi EmiliePresident & COOMay 14 '24Sale195.901,500293,850204,436May 15 04:24 PM
Armstrong BrianChairman and CEOMay 13 '24Sale202.0723,0754,662,767526May 15 04:16 PM
Ehrsam Frederick Ernest IIIDirectorMay 08 '24Sale212.0816,3803,473,9150May 10 04:47 PM
CEPU - Central Puerto ADR - Stock Price Chart
TickerCEPU [NYSE]
CompanyCentral Puerto ADR
CountryArgentina
IndustryUtilities - Regulated Electric
Market Cap1.66BEPS (ttm)2.31
P/E4.73EPS this Y350.00%
Forward P/E9.53EPS next Y6.48%
PEG0.16EPS past 5Y-3.51%
P/S1.94EPS next 5Y29.60%
P/B1.60EPS Q/Q2026.99%
Dividend1.46%Sales Q/Q172.54%
Insider Own-Inst Own3.92%
Insider Trans-Inst Trans-
Short Float0.59%EarningsMay 13/b
Analyst Recom3.00Target Price30.15
Avg Volume374.95K52W Range4.74 - 11.60
Central Puerto SA engages in the generation and distribution of electricity. It operates through the following segments: Electric Power Generation from Conventional Sources; Electric Power Generation from Renewable Sources; Natural Gas Transport and Distribution; and Others. The Natural Gas Transport and Distribution segment provides natural gas distribution public sector service in the Cuyo and Centro regions of Argentina and it is also engaged in the natural gas transport sector service. The company was founded in 1989 and is headquartered in Buenos Aires, Argentina.
INMB - INmune Bio Inc - Stock Price Chart
TickerINMB [NASD]
CompanyINmune Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap224.70MEPS (ttm)-1.92
P/E-EPS this Y-61.08%
Forward P/E-EPS next Y5.02%
PEG-EPS past 5Y-5.50%
P/S1728.47EPS next 5Y-
P/B7.03EPS Q/Q-67.93%
Dividend-Sales Q/Q-63.16%
Insider Own35.35%Inst Own12.58%
Insider Trans0.00%Inst Trans-4.42%
Short Float13.55%EarningsMay 09/a
Analyst Recom1.33Target Price19.67
Avg Volume116.98K52W Range6.50 - 14.74
May-13-24 11:54AM INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 04:05PM INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update (GlobeNewswire)
May-07-24 08:00AM INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9 (GlobeNewswire)
Apr-30-24 08:00AM INmune Bio Inc. Provides Update on Two Patients from the Phase 1b Alzheimer's Disease Trial who Continue to Receive XPro Under Compassionate Use for Over Three Years (GlobeNewswire)
Apr-29-24 08:00AM INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer (GlobeNewswire)
Apr-25-24 09:00AM INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire)
Apr-23-24 08:00AM INmune Bio Inc. Announces 24-Month Stability Validation of XPro for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay (GlobeNewswire)
Apr-22-24 08:00AM INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds Through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering (GlobeNewswire) +26.94%
Apr-08-24 08:00AM INmune Bio Inc. Presents Data on INB03's Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024 (GlobeNewswire)
Apr-01-24 10:20AM INmune Bio, Inc. (NASDAQ:INMB) Q4 2023 Earnings Call Transcript (Insider Monkey)
INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer's disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Juda ScottDirectorNov 10 '23Buy6.957,00048,65037,000Nov 13 11:31 AM
Schroeder Timothy jDirectorJul 12 '23Sale11.0110,000110,08582,187Jul 14 04:05 PM
PRTA - Prothena Corporation plc - Stock Price Chart
TickerPRTA [NASD, RUT]
CompanyProthena Corporation plc
CountryIreland
IndustryBiotechnology
Market Cap1.20BEPS (ttm)-3.25
P/E-EPS this Y-70.41%
Forward P/E-EPS next Y9.28%
PEG-EPS past 5Y6.83%
P/S13.49EPS next 5Y34.07%
P/B2.39EPS Q/Q-50.67%
Dividend-Sales Q/Q-97.69%
Insider Own13.65%Inst Own98.65%
Insider Trans-0.20%Inst Trans-4.11%
Short Float14.54%EarningsMay 08/a
Analyst Recom1.44Target Price64.75
Avg Volume582.35K52W Range19.65 - 77.13
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm's clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walker Karin LChief Accounting OfficerJan 24 '24Option Exercise13.535,00067,6505,000Jan 24 07:01 PM
Walker Karin LChief Accounting OfficerJan 24 '24Sale34.005,000170,0000Jan 24 07:01 PM
Walker Karin LChief Accounting OfficerDec 20 '23Option Exercise13.535,00067,6505,000Dec 20 07:17 PM
Walker Karin LChief Accounting OfficerDec 20 '23Sale37.195,000185,9520Dec 20 07:17 PM
Walker Karin LChief Accounting OfficerNov 30 '23Option Exercise13.535,00067,6505,000Nov 30 06:24 PM
FNCH - Finch Therapeutics Group Inc - Stock Price Chart
TickerFNCH [NASD]
CompanyFinch Therapeutics Group Inc
CountryUSA
IndustryBiotechnology
Market Cap3.38MEPS (ttm)-10.14
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-37.86%
P/S-EPS next 5Y41.70%
P/B0.18EPS Q/Q93.95%
Dividend-Sales Q/Q-100.00%
Insider Own66.31%Inst Own12.61%
Insider Trans-0.90%Inst Trans112.99%
Short Float4.88%Earnings-
Analyst Recom1.00Target Price10.00
Avg Volume52.73K52W Range1.86 - 16.74
Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SMISEK JEFFERY ADirectorMar 28 '24Sale2.576,64217,0700Mar 29 04:15 PM
SMISEK JEFFERY ADirectorMar 28 '24Sale2.611,6004,1766,512Mar 29 04:15 PM
SMISEK JEFFERY ADirectorNov 22 '23Sale3.641,4705,3516,642Nov 27 04:54 PM
Graf Susan EDirectorJun 09 '23Buy0.275,0101,3535,010Jun 09 04:15 PM
RKDA - Arcadia Biosciences Inc - Stock Price Chart
TickerRKDA [NASD]
CompanyArcadia Biosciences Inc
CountryUSA
IndustryPackaged Foods
Market Cap1.80MEPS (ttm)-5.29
P/E-EPS this Y66.53%
Forward P/E-EPS next Y16.79%
PEG-EPS past 5Y39.82%
P/S0.33EPS next 5Y14.96%
P/B0.37EPS Q/Q83.61%
Dividend-Sales Q/Q-16.83%
Insider Own3.19%Inst Own47.03%
Insider Trans3.67%Inst Trans-
Short Float1.78%EarningsMay 09/a
Analyst Recom1.00Target Price11.00
Avg Volume26.89K52W Range1.85 - 5.60
Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schaefer Thomas J.Chief Financial OfficerFeb 01 '24Buy2.067001,4421,419Feb 05 04:29 PM
Schaefer Thomas J.Chief Financial OfficerAug 04 '23Buy3.676492,382719Aug 07 07:55 PM
Jacot Stanley JrChief Executive OfficerMay 30 '23Buy4.315,00021,5505,000May 30 06:24 PM
HIVE - HIVE Digital Technologies Ltd. - Stock Price Chart
TickerHIVE [NASD]
CompanyHIVE Digital Technologies Ltd.
CountryCanada
IndustryCapital Markets
Market Cap262.55MEPS (ttm)-0.64
P/E-EPS this Y76.24%
Forward P/E-EPS next Y-23.13%
PEG-EPS past 5Y-32.45%
P/S2.74EPS next 5Y-
P/B1.29EPS Q/Q92.76%
Dividend-Sales Q/Q118.26%
Insider Own0.49%Inst Own34.43%
Insider Trans0.00%Inst Trans-
Short Float4.09%EarningsFeb 13/b
Analyst Recom2.00Target Price4.75
Avg Volume2.65M52W Range2.18 - 6.84
HIVE Digital Technologies Ltd. engages in building a bridge from the block chain sector to traditional capital markets. It also involves in the production of mined cryptocurrency like Ethereum around the clock. Its project include Iceland Cryptocurrency Mining. The company was founded on June 24, 1987 and is headquartered in Vancouver, Canada.
GLSI - Greenwich LifeSciences Inc - Stock Price Chart
TickerGLSI [NASD]
CompanyGreenwich LifeSciences Inc
CountryUSA
IndustryBiotechnology
Market Cap189.98MEPS (ttm)-0.69
P/E-EPS this Y-11.76%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-36.91%
P/S-EPS next 5Y-
P/B28.28EPS Q/Q3.13%
Dividend-Sales Q/Q-
Insider Own54.73%Inst Own5.31%
Insider Trans0.93%Inst Trans-23.11%
Short Float3.24%Earnings-
Analyst Recom1.00Target Price36.00
Avg Volume48.91K52W Range7.58 - 21.44
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patel SnehalCEO and CFOApr 01 '24Buy19.083,00057,2405,350,777Apr 03 06:10 AM
Patel SnehalCEO and CFOMar 22 '24Buy19.982,50049,9505,347,777Mar 26 06:05 AM
Patel SnehalCEO and CFOMar 20 '24Buy17.681,50026,5205,345,277Mar 22 06:02 AM
Patel SnehalCEO and CFOMar 05 '24Buy12.4930,500380,9455,343,777Mar 07 06:05 AM
Patel SnehalCEO and CFOMar 04 '24Buy13.034,10053,4235,340,277Mar 06 06:05 AM
SHOT - Safety Shot Inc - Stock Price Chart
TickerSHOT [NASD]
CompanySafety Shot Inc
CountryUSA
IndustryBeverages - Non-Alcoholic
Market Cap72.35MEPS (ttm)-0.47
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-43.19%
P/S19.93EPS next 5Y-
P/B7.61EPS Q/Q62.58%
Dividend0.00%Sales Q/Q-85.35%
Insider Own30.30%Inst Own10.83%
Insider Trans0.03%Inst Trans0.71%
Short Float10.78%Earnings-
Analyst Recom1.00Target Price2.76
Avg Volume1.08M52W Range0.26 - 7.50
Safety Shot, Inc. engages in the business of developing cannabidiol (CBD) based medical therapeutics and wellness products. It operates under the Sales and Development of CBD Based Skin Care and Therapeutic Products, and Sales and Merchandise Sold to Theme Parks segments. The company was founded by Brian S. John on October 24, 2018 and is headquartered in Jupiter, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gulyas JohnDirectorDec 28 '23Buy3.882,5009,7001,687,166Jan 02 07:46 AM
Gulyas JohnDirectorDec 28 '23Buy3.882,5009,7001,687,166Dec 28 04:05 PM
18910111213141516171820